Abstract
A general route for preparing side chain ether analogues of lovastatin is presented. These analogues proved to be weaker inhibitors of HMG-CoA reductase than the corresponding side chain ester analogues. Interestingly, inhibitory potency was enhanced markedly when the 4-fluoro group was incorporated in the aromatic moiety of the side chain benzyl group of 2d.
MeSH terms
-
Chemical Phenomena
-
Chemistry
-
Esters
-
Ethers
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
-
Lovastatin / analogs & derivatives*
-
Lovastatin / chemical synthesis
-
Lovastatin / pharmacology
-
Molecular Structure
-
Structure-Activity Relationship
Substances
-
Esters
-
Ethers
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
6-(2-(8-((4-fluorobenzyl)oxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthyl)ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
-
Lovastatin